BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Synosia Therapeutics 

601 Gateway Boulevard
Suite 1200
South San Francisco  California  94080  U.S.A.
Phone: 650-244-4850 Fax: 650-244-4874


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
BioTie Therapies Corp. to Acquire CNS Therapeutics Firm Synosia Therapeutics in $121.5M All-Shares Deal 1/11/2011 8:43:32 AM    More...
Synosia Therapeutics Presents Data from Clinical Trial of SYN-118 As A New Treatment For Parkinson's Disease 9/29/2010 9:52:51 AM    More...
Synosia Therapeutics' SYN-115 Improves Motor and Non-Motor Function in Patients with Mild- to-Moderate Parkinson's Disease 4/14/2010 10:42:04 AM    More...
Synosia Therapeutics' SYN-115 Improves Motor and Non-Motor Function in Patients with Mild- to-Moderate Parkinson's Disease 4/14/2010 6:31:16 AM    More...
Synosia Therapeutics Announces Positive Interim Results for Potential First-in-Class Treatment for Parkinson's Disease 2/1/2010 10:52:59 AM    More...
Synosia Therapeutics Announces Second Agreement with Roche (RHHBY) 3/10/2009 7:39:19 AM    More...
Synosia Therapeutics Raises CHF32 Million in Series B Private Financing 1/7/2009 7:05:33 AM    More...
Synosia Therapeutics Starts Phase II Efficacy Trial For Rufinamide 3/31/2008 7:37:26 AM    More...
Synosia Therapeutics Appoints Chief Financial Officer to New Company Headquarters in Switzerland 2/4/2008 7:51:51 AM    More...
Synosia Therapeutics Announces Encouraging Results of Proof-of-Concept Clinical Trial for Epilepsy Drug 1/22/2008 8:12:44 AM    More...
12